Skip to content

Suprapatellar Versus Infrapatellar Nailing in Tibial Fractures: A Pilot Study

Randomized Clinical Trial of Suprapatellar Versus Infrapatellar Tibial Nailing: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01341418
Acronym
SP-Pilot
Enrollment
40
Registered
2011-04-25
Start date
2011-04-30
Completion date
2016-01-31
Last updated
2017-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tibial Fractures

Keywords

tibia, suprapatellar

Brief summary

This study compares two techniques for the fixation of tibial fractures. The techniques are the suprapatellar (above knee)or infrapatellar (below knee) approach to tibial intramedullary nailing. Null hypothesis: There is no difference in 1) residual post-operative pain levels, 2)knee function, 3) healing and alignment of the tibia, or 4) trochlear changes in the patello-femoral cartilage between patients who are randomized to receive tibial nail insertion through either a suprapatellar nail entry portal or a standard patellar tendon approach.

Detailed description

Patients undergoing tibial fracture repair will be consented and randomized into one of the two techniques, with arthroscopic photos taken before and after nail insertion to study the condition of the patello-femoral cartilage. Enrolled patients will be followed for one year in clinic.

Interventions

Suprapatellar surgical approach will be used for intramedullary nailing of tibial fractures. Arthroscopic photos will be obtained before and after nail insertion. Postoperative radiographs, outcome questionnaires and an MRI will be performed over ther course of one-year follow-up.

The Infrapatellar surgical approach will be used for intramedullary nailing of tibial fractures. No arthroscopic examination for this intervention. Postoperative radiographs, outcome questionnaires and an MRI will be performed over ther course of one-year follow-up.

Sponsors

Orthopaedic Trauma Association
CollaboratorOTHER
Florida Orthopaedic Institute
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Tibial shaft fractures amenable and indicated for repair with intramedullary nails, with or without the use of reaming * Acute tibial fractures within 4 weeks of injury * Closed or open tibial fractures after appropriate irrigation and debridement * Fractures must be within metaphyseal/diaphyseal junctures defined as middle 3/5 of tibia * Skeletally mature patient * Age 18 and above.

Exclusion criteria

* Tibial shaft fractures that require articular reconstruction with plates * Any tibial fracture extending \> 1 cm into the proximal or distal 1/5 of tibia * Tibial plateau fractures * Pilon fractures * Periprosthetic fractures * Non-unions * Prior knee surgery * History of gout or rheumatoid or osteoarthritis * Concomitant injury to same limb (including any traumatic injury to ipsilateral knee, femur or foot, and knee dislocation) * Spinal injury * Prisoner or high likelihood of incarceration * Not likely to follow-up in the estimation of surgeon * Pregnant females

Design outcomes

Primary

MeasureTime frameDescription
residual postoperative knee pain1 yearA Visual Analog Scale (VAS) will be used for knee pain, as well as a pain location diagram and a Lysholm knee score.

Secondary

MeasureTime frameDescription
union/alignment of tibia3 months postoperativelyAP and lateral radiographs will be used to evaluate union/alignment of the tibia.
knee function6 months postoperativelyA Lysholm knee score will be used to evaluate knee function, as well as range of motion (ROM) measurements.
trochlear changes in the patello-femoral cartilage1 yearPre- and post-nailing arthroscopic photos and an MRI at 12 months postoperative will be used to evaluate trochlear changes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026